What is Calcium Cyclamate?
Calcium cyclamate (CAS Number: 5897-16-5) is the calcium salt of cyclohexylsulfamic acid, a synthetic non-nutritive sweetener that provides sweetness without contributing calories. It is approximately 30-40 times sweeter than table sugar (sucrose) and was developed in the 1930s. The compound consists of a cyclohexyl ring attached to a sulfamic acid moiety, making it structurally distinct from other artificial sweeteners.
Common Uses
Historically, calcium cyclamate was used in a variety of food and beverage applications, including:
- Soft drinks and carbonated beverages
- Tabletop sweetener products
- Processed desserts and confections
- Canned fruits and preserves
- Pharmaceutical formulations and sugar-free medications
- Dairy products and yogurts
At its peak usage in the 1960s, cyclamate was one of the most widely consumed artificial sweeteners in North America and Europe. However, its use has been substantially restricted or eliminated in many markets.
Safety Assessment
Calcium cyclamate underwent toxicological evaluation in multiple regulatory jurisdictions. The FDA received zero adverse event reports and zero recalls related to cyclamate, indicating no documented safety incidents from consumer use. However, the regulatory prohibition was not based on observed adverse events but rather on precautionary findings from laboratory studies.
In animal studies, some research suggested potential bladder hyperplasia and other findings in rats, though these observations occurred at high dose levels. The metabolic fate of cyclamate also varied between species, with some animals metabolizing it to cyclohexylamine, a compound that raised additional regulatory concerns. These laboratory findings prompted regulatory agencies to exercise a precautionary approach, prioritizing restriction over continued approval.
It is important to note that the absence of documented adverse events in humans does not necessarily indicate a substance is approved; regulatory decisions incorporate toxicology data, metabolic studies, and risk assessment protocols beyond epidemiological evidence.
Regulatory Status
Calcium cyclamate has a complex regulatory history:
**United States**: The FDA prohibited cyclamate in 1969 based on animal study results. The substance is not approved as a food additive and remains prohibited in the U.S. food supply.
**European Union**: Cyclamate is permitted in the EU (E952) under specific conditions and usage levels, as the European Food Safety Authority (EFSA) reached different conclusions from the FDA regarding the relevance of animal findings to human health.
**Canada**: The additive was banned but was reapproved in 2001 for use in specific food categories with restricted maximum levels.
**Other Countries**: Regulations vary significantly by jurisdiction, with some nations permitting use and others prohibiting it entirely.
This divergence in regulatory decisions reflects different approaches to interpreting the same toxicological data and different regulatory philosophies regarding food additive approval.
Key Studies
The primary studies informing regulatory decisions on cyclamate include early rat feeding studies conducted in the 1960s that reported findings in the urinary bladder at high dose levels. Subsequent research examined the potential for conversion to cyclohexylamine and metabolic differences between animal species. The EFSA's re-evaluation of cyclamate in the 1990s-2000s concluded that findings in rats were not necessarily predictive of human responses at typical dietary exposure levels, leading to different regulatory conclusions than the FDA.
Scientific debate regarding cyclamate highlights the challenges regulators face when interpreting animal toxicology data and applying safety factors to establish human dietary exposure limits.